The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 12, 2025
Filed:
May. 22, 2017
Applicant:
Insulet Corporation, Acton, MA (US);
Inventors:
Lane Desborough, Milpitas, CA (US);
Bryan Mazlish, Milpitas, CA (US);
Assignee:
Insulet Corporation, Acton, MA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G16H 40/63 (2018.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61M 5/00 (2006.01); A61M 5/142 (2006.01); A61M 5/172 (2006.01); G16H 20/17 (2018.01);
U.S. Cl.
CPC ...
A61B 5/14532 (2013.01); A61B 5/7275 (2013.01); A61M 5/003 (2013.01); A61M 5/14244 (2013.01); A61M 5/14248 (2013.01); A61M 5/14276 (2013.01); A61M 5/1723 (2013.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01); A61B 5/0031 (2013.01); A61B 5/4836 (2013.01); A61M 2005/14268 (2013.01); A61M 2005/14296 (2013.01); A61M 2205/3569 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2205/8206 (2013.01); A61M 2230/201 (2013.01);
Abstract
A method may include obtaining blood glucose level readings over a diurnal period for each of a plurality of days and determining an estimated variability of the blood glucose levels over the diurnal period for the plurality of days. The method may also include modifying, based on the estimated variability of the blood glucose level, a target blood glucose level to a modified target blood glucose level, and delivering insulin, using an insulin pump, during the diurnal period based on the modified target blood glucose level.